(1)
Bioabsorbable Vascular Scaffolds Eluting With Everolimus: For Percutaneous Coronary Intervention of Patients With De-Novo Coronary Artery Lesion: Our Experiences at a Tertiary Hospital. Cardiovasc. j. 2014, 6 (2), 122-126. https://doi.org/10.3329/cardio.v6i2.18352.